Supplier in the UAE, Saudi Arabia & Egypt
Patented rapid microbial-load testing based on ATP bioluminescence, cutting sterility-test turnaround from 14 days to around 2.
Arab Lab supplies Promicol rapid sterility testing to pharmaceutical, biotech and cell therapy manufacturers in the UAE, Saudi Arabia and Egypt. Promicol’s patented products measure microbial load by ATP bioluminescence, so a result that conventionally takes two weeks can be available in about two days.
Promicol produces a large array of patented products for rapid testing of microbial load, based on the ATP bioluminescence method: reagents isolate microbial ATP specifically, and the light output — measured in Relative Light Units — confirms sterility.
The Promilite M1 and M4 readers, at the core of the PRENOVA® platform, cut sterility-test turnaround from the conventional 14 days down to approximately 2 days.
The PRENOVA® TCT3 assay differentiates human from microbial ATP, shortening sterility-test release time to 2–3 days for T-cell therapies — relevant given the rapid growth of CAR-T therapies in advanced cancer treatment. The NOVILITE reader is a luminometer engineered specifically for the kinetic sensitivity the TCT3 assay requires.
At a glance
- Method
- ATP bioluminescence
- Turnaround
- 14 days → approximately 2 days
- Platform
- PRENOVA®
Promicol product categories
The main areas of the Promicol portfolio. Ask us for the current range available in your country.
PRENOVA® platform
The rapid sterility testing platform built around Promicol’s readers and reagents.
Promilite M1 and M4 readers
The instruments at the core of the PRENOVA® platform.
PRENOVA® TCT3 assay
An assay that differentiates human from microbial ATP, for T-cell therapy release in 2–3 days.
NOVILITE luminometer
A reader engineered for the kinetic sensitivity the TCT3 assay requires.
ATP reagents
Reagents that isolate microbial ATP specifically, so the light signal reflects microbial contamination.
What Promicol brings to the lab.
Promilite M1 & M4 readers
The core of the PRENOVA® platform for rapid sterility testing.
PRENOVA® TCT3 assay
Differentiates human from microbial ATP for T-cell therapy release in 2–3 days.
NOVILITE luminometer
Engineered for the kinetic sensitivity the TCT3 assay requires.
Rapid sterility release
Approximately 2 days instead of the conventional 14.
Applications and industries
Promicol methods are used where release time matters: sterile products with short shelf lives, cell therapies that cannot wait for a 14-day result, and QC laboratories that want earlier detection of contamination. The light output, measured in Relative Light Units, confirms sterility.
- Sterile pharmaceutical manufacturing
- Biopharmaceuticals
- Cell and gene therapy, including CAR-T
- QC microbiology laboratories
Available across the UAE, Saudi Arabia and Egypt
Requests for Promicol are handled by the Arab Lab office that covers your country.
Promicol: frequently asked questions
How does Promicol’s rapid sterility test work?
Reagents isolate microbial ATP and a luminometer measures the light produced, in Relative Light Units. The light output confirms whether the sample is sterile.
How much faster is it than the conventional sterility test?
The Promilite M1 and M4 readers on the PRENOVA® platform cut turnaround from the conventional 14 days to approximately 2 days. Like any alternative microbiological method, it is validated for each product before it is used for release.
Can it be used for cell therapies?
Yes. The PRENOVA® TCT3 assay differentiates human from microbial ATP, shortening sterility-test release to 2–3 days for T-cell therapies.
How do I start an evaluation?
Contact Arab Lab with your product type and current sterility-testing method, and the Life Science team will discuss the next step.
The rest of the portfolio.
Talk to a specialist.
Tell us what the lab needs to measure, make or release. We route every request to the right Arab Lab department.